Total Clarity Wealth Management, Inc. Aurinia Pharmaceuticals Inc. Transaction History

Total Clarity Wealth Management, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	BUY	$8.95 - $12.8 $23,153 - $33,113	2,587 New	2,587 $26,000
Q1 2022 Apr 29, 2022	SELL	$10.05 - $22.48 $84,791 - $189,663	-8,437 Closed	0 $0
Q4 2021 Feb 03, 2022	BUY	$17.78 - $33.08 $111,569 - $207,577	6,275 Added 290.24%	8,437 $193,000
Q3 2021 Oct 21, 2021	BUY	$10.93 - $23.55 $23,630 - $50,915	2,162 New	2,162 $48,000
Q2 2021 Jul 26, 2021	SELL	$10.0 - $14.52 $113,330 - $164,555	-11,333 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$12.3 - $18.73 $10,983 - $16,725	893 Added 8.55%	11,333 $147,000
Q4 2020 Jan 20, 2021	BUY	$12.94 - $16.05 $672 - $834	52 Added 0.5%	10,440 $144,000
Q3 2020 Nov 17, 2020	SELL	$13.19 - $16.66 $6,924 - $8,746	-525 Reduced 4.81%	10,388 $153,000
Q2 2020 Jul 15, 2020	BUY	$14.12 - $18.33 $6,777 - $8,798	480 Added 4.6%	10,913 $177,000
Q1 2020 Apr 24, 2020	SELL	$11.34 - $21.46 $12,802 - $24,228	-1,129 Reduced 9.76%	10,433 $151,000
Q4 2019 Feb 27, 2020	BUY	$3.88 - $21.42 $44,860 - $247,658	11,562 New	11,562 $234,000

191

56.2M

499K

637K

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.03B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.